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Protein folding: A missing redox link in the endoplasmic reticulum
Robert B. Freedman, Angela D. Dunn and Lloyd W. Ruddock
Native disulphide-bond formation during protein
folding in the endoplasmic reticulum requires oxidative
machinery, the components and mechanism of which
are not yet fully understood. Two recent papers have
identified a novel protein component that appears to
play a key role in this important redox pathway.
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The lumen of the endoplasmic reticulum (ER) is a com-
partment specialized for protein folding; proteins des-
tined for secretion, or for compartments accessed via the
secretory pathway, enter the ER lumen unfolded, but
leave it only when they are correctly folded and assem-
bled. Recent work has focused on the nature of the
quality control system at this point, but there is still
much to be learnt about the cellular machinery responsi-
ble for folding and assembly in the ER. What is clear is
that protein folding in this context is generally associated
with the formation of native disulphide bonds, and that
this is facilitated by an enzyme, protein disulphide iso-
merase (PDI), and by its more recently discovered homo-
logues [1]. PDI is an excellent catalyst of
disulphide-bond formation and isomerization, but any
model for the way it acts on nascent proteins requires the
additional participation of an oxidant, either to oxidize
the substrate randomly (allowing PDI to act as an iso-
merase) or to reoxidize PDI (after it has acted as a direct
oxidant towards reduced protein substrates). The iden-
tity of this partner oxidant remains obscure, but two
recent parallel papers provide clues and a route for
further investigation [2,3].
Various proposals have been put forward concerning the
source of oxidizing equivalents for protein disulphide-
bond formation in the ER lumen. Over 20 years ago, it
was suggested (but never subsequently substantiated)
that the immediate oxidant was cystamine, generated
within the ER from cysteamine by a specific oxidase [4],
implying that molecular oxygen was the ultimate
oxidant. More recently, work on the vitamin-K-depen-
dent system for carboxylation of nascent proteins sug-
gested a link between this system and the system for
protein disulphide-bond formation; if this were so, it
would imply that vitamin K and its epoxide were the
immediate source of oxidizing equivalents for protein
disulphide-bond formation [5]. 
On the other hand, for many years it has been a strong pre-
sumption that the oxidant immediately involved is oxidized
glutathione, the oxidized form of the eukaryotic cell’s major
low molecular weight thiol compound. This presumption
has been strengthened by a direct study of the redox state
of glutathione in the ER [6], which showed that glutathione
is present in the compartment at an overall concentration
similar to that in the cytosol, but in much more oxidizing
proportions. There is also substantial biochemical evidence
in favour of a role for glutathione. Studies on the post-trans-
lational oxidation of nascent proteins in the luminal volume
of isolated microsomes show that oxidized glutathione
added externally is a very effective and rapid oxidant [7,8].
In addition, studies of the secretion by yeast of recombinant
mutant lysozymes have indicated that unpaired cysteine
residues, lacking their normal disulphide-bonding partner,
are instead secreted while disulphide-bonded to glu-
tathione [9], suggesting a direct role for glutathione in
protein oxidation. Glutathione cannot, however, be the
whole story. How are the oxidizing equivalents transferred
into the ER? Is it via a transport system actively concentrat-
ing oxidized glutathione, or is there an electron transfer
pathway in the ER membrane that is involved in the deliv-
ery of oxidizing equivalents to nascent proteins? The two
recent papers [2,3] strongly suggest the latter scenario.
The ERO1 gene (endoplasmic reticulum oxidoreductin 1,
YML130c) from the yeast Saccharomyces cerevisiae was iso-
lated by the two groups [2,3] using independent screens for
temperature-sensitive mutants, with subsequent confirma-
tion of the identification of ERO1 by selecting for genes
from a yeast genomic library which complemented the
defective phenotypes. Frand and Kaiser [2] screened tem-
perature-sensitive mutants for defects in the export of
secretory proteins from the ER, whereas Pollard et al. [3]
exploited the fact that any mutant defective in components
of the redox pathway may be sensitive to the reductant
dithiothreitol (DTT), so they screened temperature-sensi-
tive mutants for DTT sensitivity. In a separate, more direct
screen, Pollard et al. [3] also isolated the ERO1 gene from a
genomic library by selecting for growth on normally lethal
levels of DTT. Both groups reported that the ERO1
mutants are sensitive to DTT, and conversely that overex-
pression of the wild-type ERO1 gene leads to DTT resis-
tance. The DTT sensitivity, together with genetic analysis
by both groups which established that the ERO1 gene is
essential for viability in S. cerevisiae, indicates that the ERO1
gene product, Ero1p, may play a crucial role in the cell.
Ero1p has a predicted molecular weight of 65 kDa, a
putative amino-terminal signal sequence that directs ER
localization and nine potential N-linked glycosylation
sites. Genes homologous to S. cerevisiae ERO1 are present
in a wide range of eukaryotes including humans, suggest-
ing conservation of function. Within the most highly con-
served region of Ero1p is the sequence
Cys–X–X–Cys–X–X–Cys (where X is any amino acid), a
motif that specifies part of the binding site for an
iron–sulphur cluster in proteins related to ferredoxin.
Tagging an epitope to the carboxyl terminus of Ero1p
allowed both groups to elucidate that the protein is N-gly-
cosylated, but the glycosyl moiety does not contain α1–6
mannose [2], suggesting that the tagged protein is
restricted to the ER. In addition, Pollard et al. [3] indicate
that epitope tagging of Ero1p may have an effect on its
activity in vivo. More direct evidence for the localization
of Ero1p comes from immunofluorescence experiments
which showed that it colocalizes with the known ER-resi-
dent protein Kar2p/BiP [3]. Given that Ero1p does not
contain the classic yeast ER-retention signals HDEL
(His–Asp–Glu–Leu) or KKXX (Lys–Lys–any–any), it was
suggested that Ero1p is retained in the ER by being
tightly associated with the membrane, or with membrane
components. This suggestion is indirectly supported by
the requirements for extraction of tagged Ero1p from
membrane-containing fractions of cell extracts [2].
Both groups have demonstrated that Ero1p is linked to
the formation of disulphide bonds in the ER, by showing
that the transport of invertase from the ER was indepen-
dent of the presence of Ero1p while that of carboxypepti-
dase Y required Ero1p. The transport of invertase is
known to be independent of redox status — for example,
it is unaffected by the presence of DTT — while that of
carboxypeptidase Y requires the formation of its five
native disulphide binds and is blocked by the presence of
DTT. In addition Frand and Kaiser [2] showed that the
dependence on Ero1p that is seen for the transport of car-
boxypeptidase Y is also seen for Gas1p, a protein which
may contain up to seven disulphide bonds in its extracel-
lular domain. This effect on the secretion of disulphide-
bond-containing proteins, combined with the link
between DTT sensitivity and Ero1p production, is consis-
tent with the prediction that ERO1 is involved in the
system for maintaining the redox state of the ER. 
The idea that ERO1 is involved in maintaining the ER’s
redox state is further supported by the finding of Frand
and Kaiser [2] that addition of the oxidant diamide, at the
correct concentrations, reverses the effects of the loss of
Ero1p. In contrast, in a mutant strain that lacks the PDI-
encoding PDI1 gene, addition of diamide does not reverse
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Figure 1
Potential schemes for the oxidation of nascent
secretory proteins. The protein substrate (P)
may be oxidized (a) directly by Ero1p or
(b) by oxidized glutathione, which in turn is
reoxidized by Ero1p. In this case, PDI is acting
primarily as an isomerase. Alternatively PDI
may be acting as the oxidant, as well as an
isomerase, with the oxidizing equivalents to
reoxidize PDI coming either from Ero1p, from
oxidized glutathione or from another oxidant.
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the effects of the loss of PDI, indicating that Ero1p and
PDI perform distinct functions (and both are essential). In
addition, both groups also found that synthesis of Ero1p is
induced, like the synthesis of other ER-resident proteins,
in response to an increase in unfolded proteins in the ER,
and Ero1p contains an unfolded-protein response element
(UPRE) in its promoter. Pollard et al. [3] additionally
found, by using reporter constructs under the transcrip-
tional control of the Kar2 UPRE, that ERO1 mutants not
only show an induction of the unfolded-protein response,
but that this response is induced in the mutants even in
the absence of stress, indicating that an ERO1 mutation
leads to a more general defect in the folding of proteins in
the secretory pathway.
The two papers make a strong case that Ero1p is involved
in the pathway of secretory protein oxidation in yeast, and
the presence of genes homologous to ERO1 across a wide
range of eukaryotes suggests that the pathway is con-
served. The work provides little direct biochemical evi-
dence, however, and only limited indirect information on
the properties of Ero1p. This makes it difficult to recon-
struct the complete pathway and to identify all the compo-
nents and their interactions. The suggestion that Ero1p is
a membrane-associated ferredoxin-like protein is plausible
and worth further investigation, but the identity of its
redox partners remains obscure. There are no clues yet
about the source from which it derives its oxidizing equiv-
alents, nor about the target to which it transfers them.
Does it oxidize an intermediate carrier, such as glu-
tathione, does it act directly on reduced proteins (which
are then isomerized by PDI) or does it recycle PDI from
the reduced to the oxidized state (see Figure 1)?
The evidence, as yet, is inconclusive; Pollard et al. [3]
even suggest that Ero1p may be a sensor rather than an
active component of the pathway, while Frand and
Kaiser [2] suggest that there is no requirement for oxi-
dized glutathione as an oxidant. These contradictions
demonstrate that there is still a large gap in our knowl-
edge of a key redox pathway in secretory cells. The great
value of the two recent papers is that they have placed a
large piece into this gap in the jigsaw puzzle, and they are
therefore bound to stimulate and facilitate the search for
the adjacent pieces. 
References
1. Freedman RB: The formation of protein disulphide bonds. Curr
Opin Struct Biol 1995, 5:85-91.
2. Frand AR, Kaiser CA: The ERO1 gene of yeast is required for
oxidation of protein dithiols in the endoplasmic reticulum.
Molecular Cell 1998, 1:161-170.
3. Pollard MG, Travers KJ, Weissmann JS: Ero1p: a novel and
ubiquitous protein with an essential role in oxidative protein
folding in the endoplasmic reticulum. Molecular Cell 1998,
1:171-182.
4. Ziegler DM, Poulsen LL: Protein disulphide bond synthesis: a
possible intracellular mechanism. Trends Biochem Sci 1977,
2:79-81.
5. Soute BAM, Groenen-van Dooren MMCL, Holmgren A, Lundstrom J,
Vermeer C: Stimulation of the dithiol-dependent reductases in the
vitamin K cycle by the thioredoxin system. Biochem J 1992,
281:255-259.
6. Hwang C, Sinskey AJ, Lodish HF: Oxidized redox state of
glutathione in the endoplasmic reticulum. Science 1992,
257:1496-1502.
7. Creighton TE, Bagley CJ, Cooper L, Darby NJ, Freedman RB,
Kemmink J, Sheikh A: On the biosynthesis of bovine pancreatic
trypsin inhibitor (BPTI). Structure, processing, folding and
disulphide bond formation of the precursor in vitro and in
microsomes. J Mol Biol 1993, 232:1176-1196.
8. Marquadt T, Hebert DN, Helenius A: Post-translational folding of
influenza hemagglutinin in isolated endoplasmic reticulum-
derived microsomes. J Biol Chem 1993, 268:19618-19625.
9. Hayano T, Inaka K, Otsu M, Taniyama Y, Miki K, Matsushima M,
Kikuchi M: PDI and glutathione-mediated reduction of the
glutathionylated variant of human lysozyme. FEBS Lett 1993,
328:203-208.
